Ozurdex for Retinal Vein Occlusion Study (ORVO Study).

Trial Profile

Ozurdex for Retinal Vein Occlusion Study (ORVO Study).

Phase of Trial: Phase II/III

Latest Information Update: 01 Aug 2015

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Retinal oedema; Retinal vein occlusion
  • Focus Therapeutic Use
  • Acronyms ORVO
  • Most Recent Events

    • 05 May 2015 New trial record
    • 02 Apr 2015 Status change from active, not recruiting to completed, as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top